Cheryl Gault
Geschäftsführer bei Rapport Therapeutics, Inc.
Aktive Positionen von Cheryl Gault
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Rapport Therapeutics, Inc.
 Rapport Therapeutics, Inc. BiotechnologyHealth Technology Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA. | Geschäftsführer | 07.09.2023 | - |
Karriereverlauf von Cheryl Gault
Ehemalige bekannte Positionen von Cheryl Gault
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| CYCLERION THERAPEUTICS, INC. | Geschäftsführer | 01.01.2021 | 28.07.2023 |
| Corporate Officer/Principal | 01.05.2020 | 01.01.2021 | |
| IRONWOOD PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.02.2011 | 01.04.2019 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Vertrieb & Marketing | - | - |
Ausbildung von Cheryl Gault
| Boston College | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 6 |
Operativ
| Chief Operating Officer | 2 |
| Corporate Officer/Principal | 2 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| CYCLERION THERAPEUTICS, INC. | Health Technology |
| IRONWOOD PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Rapport Therapeutics, Inc.
Rapport Therapeutics, Inc. BiotechnologyHealth Technology Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA. | Health Technology |
- Börse
- Insiders
- Cheryl Gault
- Erfahrung
